In the present work, we showed that FTS can inhibit the growth not only of a rat cell line but also of a human TSC2-deficient AML cell line, which was derived from a LAM patient and can serve as a model for LAM27 (Figure 1a). The gene discussed is AKTIP; the disease is lymphangioleiomyomatosis.